OPPM
ASND icon

Opus Point Partners Management’s Ascendis Pharma A/S ASND Stock Holding History

Opus Point Partners Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$596K Hold
6,190
– – 1.08% 21
2019
Q2 		$713K Hold
6,190
– – 1.05% 22
2019
Q1 		$729K Buy
+6,190
New +$542K 0.99% 23

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Opus Point Partners Management's ASND Position: Q3 2019 in Review

Opus Point Partners Management held its Ascendis Pharma A/S (ASND) position steady in Q3 2019 at 6,190 shares worth $596K. The position accounts for 1.08% of the portfolio, ranked #21.

Opus Point Partners Management first reported a position in ASND in Q1 2019 and has held it in 3 quarters since. The position peaked at $729K in Q1 2019. 129 funds tracked by Wall St. Rank hold ASND as of Q3 2019.

  • Opus Point Partners Management held 6,190 shares of Ascendis Pharma A/S worth $596K as of Q3 2019.
  • Opus Point Partners Management left its Ascendis Pharma A/S share count unchanged in Q3 2019.
  • Ascendis Pharma A/S made up 1.08% of Opus Point Partners Management's portfolio in Q3 2019, its #21 holding.
  • Opus Point Partners Management first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 3 quarters since.
  • Opus Point Partners Management's Ascendis Pharma A/S position peaked at $729K in Q1 2019.
  • 129 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.